Skip to main content

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

FOLD holding history

Amicus Therapeutics, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

FOLD overviewAll 13F holders of FOLDFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of FOLD by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−9,360−100.0%Sold outHolders
Q4 20259,360$133.0K<0.1%+339+3.8%AddedHolders
Q3 20259,021$71.0K<0.1%−1,203−11.8%ReducedHolders
Q2 202510,224$59.0K<0.1%00.0%UnchangedHolders
Q1 202510,224$83.0K<0.1%+35+0.3%AddedHolders
Q4 202410,189$96.0K<0.1%00.0%UnchangedHolders
Q3 202410,189$109.0K<0.1%00.0%UnchangedHolders
Q2 202410,189$101.0K<0.1%+322+3.3%AddedHolders
Q1 20249,867$116.0K<0.1%−30,418−75.5%ReducedHolders
Q4 202340,285$572.0K<0.1%−2,809−6.5%ReducedHolders
Q3 202343,094$524.0K<0.1%+602+1.4%AddedHolders
Q2 202342,492$534.0K<0.1%+3,400+8.7%AddedHolders
Q1 202339,092$434.0K<0.1%−6,426−14.1%ReducedHolders
Q4 202245,518$556.0K<0.1%+899+2.0%AddedHolders
Q3 202244,619$466.0K<0.1%+1,060+2.4%AddedHolders
Q2 202243,559$468.0K<0.1%+511+1.2%AddedHolders
Q1 202243,048$408.0K<0.1%−3,230−7.0%ReducedHolders
Q4 202146,278$535.0K<0.1%−502−1.1%ReducedHolders
Q3 202146,780$447.0K<0.1%−2,881−5.8%ReducedHolders
Q2 202149,661$479.0K<0.1%+13,052+35.7%AddedHolders
Q1 202136,609$362.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.